• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

干扰素γ在感染寄生虫的新冠病毒阳性患者中的作用。

Role of interferon gamma in SARS-CoV-2-positive patients with parasitic infections.

作者信息

Abdel-Hamed Enas Fakhry, Ibrahim Mohamed N, Mostafa Nahed E, Moawad Howayda S F, Elgammal Nahla E, Darwiesh Ehab M, El-Rafey Dina S, ElBadawy Nissreen E, Al-Khoufi Emad Ali, Hindawi Salwa I

机构信息

Medical Parasitology Department, Faculty of Medicine, Zagazig University, El Kawmia Square, Zagazig, 44511, Sharkia Governorate, Egypt.

Clinical Laboratories Department, College of Applied Medical Sciences, Jouf University, Al-Jouf, 77451, Saudi Arabia.

出版信息

Gut Pathog. 2021 May 4;13(1):29. doi: 10.1186/s13099-021-00427-3.

DOI:10.1186/s13099-021-00427-3
PMID:33947467
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8096133/
Abstract

BACKGROUND

By 27 June 2020, almost half a million people had died due to COVID-19 infections. The susceptibility and severity of infection vary significantly across nations. The contribution of chronic viral and parasitic infections to immune homeostasis remains a concern. By investigating the role of interferon (IFN)-γ, we conducted this study to understand the connection between the decrease in numbers and severity of COVID-19 cases within parasitic endemic regions. Our research included 375 patients referred to hospitals for diagnosis of COVID-19 infection. Patients were subjected to full investigations, in particular severe acute respiratory syndrome coronavirus-2 nucleic acid and Toxoplasma IgM and IgG antibody detection, stool examination, and quantitative IFN-γ measurement.

RESULTS

The majority of the studied cases had chest manifestation either alone (54.7%) or in association with gastrointestinal (GIT) manifestations (19.7%), whereas 25.6% had GIT symptoms. We reported parasitic infections in 72.8% of mild COVID-19 cases and 20.7% of severe cases. Toxoplasma gondii, Cryptosporidium, Blastocyst, and Giardia were the most common parasitic infections among the COVID-19 cases studied.

CONCLUSION

The remarkable adaptation of human immune response to COVID-19 infection by parasitic infections with high levels of IFN-γ was observed in moderate cases compared with low levels in extreme cases. The potential therapeutic efforts aimed at the role of parasitic infection in immune system modulation are needed if this hypothesis is confirmed.

摘要

背景

截至2020年6月27日,近50万人死于新冠病毒感染。各国感染的易感性和严重程度差异显著。慢性病毒和寄生虫感染对免疫稳态的影响仍令人担忧。通过研究干扰素(IFN)-γ的作用,我们开展了本研究,以了解寄生虫流行地区新冠病毒感染病例数量减少与严重程度之间的联系。我们的研究纳入了375名因新冠病毒感染到医院就诊的患者。对患者进行了全面检查,尤其包括严重急性呼吸综合征冠状病毒2核酸检测、弓形虫IgM和IgG抗体检测、粪便检查以及干扰素-γ定量检测。

结果

大多数研究病例单独出现胸部表现(54.7%)或伴有胃肠道(GIT)表现(19.7%),而25.6%有GIT症状。我们报告,72.8%的轻症新冠病毒感染病例和20.7%的重症病例存在寄生虫感染。弓形虫、隐孢子虫、芽囊原虫和贾第虫是所研究的新冠病毒感染病例中最常见的寄生虫感染。

结论

与极端病例中低水平的干扰素-γ相比,在中度病例中观察到寄生感染通过高水平的干扰素-γ对人类免疫反应对新冠病毒感染的显著适应性。如果这一假设得到证实,需要针对寄生感染在免疫系统调节中的作用进行潜在的治疗研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0993/8097978/e47fa2c449b6/13099_2021_427_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0993/8097978/e47fa2c449b6/13099_2021_427_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0993/8097978/e47fa2c449b6/13099_2021_427_Fig1_HTML.jpg

相似文献

1
Role of interferon gamma in SARS-CoV-2-positive patients with parasitic infections.干扰素γ在感染寄生虫的新冠病毒阳性患者中的作用。
Gut Pathog. 2021 May 4;13(1):29. doi: 10.1186/s13099-021-00427-3.
2
Characteristics and roles of severe acute respiratory syndrome coronavirus 2-specific antibodies in patients with different severities of coronavirus 19.新型冠状病毒 2 特异性抗体在不同严重程度新型冠状病毒肺炎患者中的特征和作用。
Clin Exp Immunol. 2020 Nov;202(2):210-219. doi: 10.1111/cei.13500. Epub 2020 Aug 7.
3
Clinical Characteristics and Outcome of Hospitalized COVID-19 Patients in a MERS-CoV Endemic Area.在中东呼吸综合征冠状病毒流行地区住院的 COVID-19 患者的临床特征和转归。
J Epidemiol Glob Health. 2020 Sep;10(3):214-221. doi: 10.2991/jegh.k.200806.002.
4
Disruption of CCR5 signaling to treat COVID-19-associated cytokine storm: Case series of four critically ill patients treated with leronlimab.破坏CCR5信号传导以治疗新冠病毒相关细胞因子风暴:使用leronlimab治疗的4例危重症患者病例系列
J Transl Autoimmun. 2021;4:100083. doi: 10.1016/j.jtauto.2021.100083. Epub 2021 Jan 6.
5
Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease 2019 (COVID-19) in Wuhan, China.中国武汉 2019 年冠状病毒病(COVID-19)住院儿科患者的临床和免疫特征。
JAMA Netw Open. 2020 Jun 1;3(6):e2010895. doi: 10.1001/jamanetworkopen.2020.10895.
6
[Evaluation of the Diagnostic Performance of Different Principles of SARS-CoV-2 Commercial Antibody Tests in COVID-19 Patients].[评估不同原理的SARS-CoV-2商业抗体检测在COVID-19患者中的诊断性能]
Mikrobiyol Bul. 2021 Apr;55(2):207-222. doi: 10.5578/mb.20219907.
7
Kinetics of viral load and antibody response in relation to COVID-19 severity.病毒载量和抗体反应动力学与 COVID-19 严重程度的关系。
J Clin Invest. 2020 Oct 1;130(10):5235-5244. doi: 10.1172/JCI138759.
8
Clinical application of combined detection of SARS-CoV-2-specific antibody and nucleic acid.新型冠状病毒2特异性抗体与核酸联合检测的临床应用
World J Clin Cases. 2020 Oct 6;8(19):4360-4369. doi: 10.12998/wjcc.v8.i19.4360.
9
Protein Coding and Long Noncoding RNA (lncRNA) Transcriptional Landscape in SARS-CoV-2 Infected Bronchial Epithelial Cells Highlight a Role for Interferon and Inflammatory Response.SARS-CoV-2 感染的支气管上皮细胞中的蛋白编码和长非编码 RNA(lncRNA)转录组阐明了干扰素和炎症反应的作用。
Genes (Basel). 2020 Jul 7;11(7):760. doi: 10.3390/genes11070760.
10
Highlighted Prospects of an IgM/IgG Antibodies Test in Identifying Individuals With Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection.IgM/IgG 抗体检测在识别无症状严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)感染个体方面的显著前景。
Arch Pathol Lab Med. 2021 Jan 1;145(1):39-45. doi: 10.5858/arpa.2020-0310-SA.

引用本文的文献

1
Frequency of exposure to Toxoplasma gondii in COVID-19 patients: a systematic review and meta-analysis.COVID-19 患者感染弓形虫的频率:系统评价和荟萃分析。
BMC Public Health. 2024 Oct 19;24(1):2885. doi: 10.1186/s12889-024-20334-x.
2
Genetic diversity and seroprevalence of Toxoplasma gondii in COVID‑19 patients; a first case-control study in Iran.COVID-19 患者弓形虫的遗传多样性和血清流行率;伊朗的首例病例对照研究。
BMC Infect Dis. 2024 Jan 3;24(1):42. doi: 10.1186/s12879-023-08964-9.
3
Evaluation of immunogenicity-induced DNA vaccines against different SARS-CoV-2 variants.

本文引用的文献

1
Lower Circulating Interferon-Gamma Is a Risk Factor for Lung Fibrosis in COVID-19 Patients.循环中较低水平的干扰素-γ是 COVID-19 患者肺纤维化的一个风险因素。
Front Immunol. 2020 Sep 29;11:585647. doi: 10.3389/fimmu.2020.585647. eCollection 2020.
2
Critical adjustments in a department of orthopaedics through the COVID-19 pandemic.通过 COVID-19 大流行对矫形外科部门的重大调整。
Int Orthop. 2020 Aug;44(8):1557-1564. doi: 10.1007/s00264-020-04647-1. Epub 2020 May 30.
3
Failure in initial stage containment of global COVID-19 epicenters.
评估针对不同 SARS-CoV-2 变体的免疫原性诱导 DNA 疫苗。
PLoS One. 2023 Dec 7;18(12):e0295594. doi: 10.1371/journal.pone.0295594. eCollection 2023.
4
Clinical and Immunological Impacts of Latent Toxoplasmosis on COVID-19 Patients.潜伏性弓形虫病对COVID-19患者的临床和免疫学影响。
Cureus. 2023 Sep 26;15(9):e45989. doi: 10.7759/cureus.45989. eCollection 2023 Sep.
5
Association between breakthrough infection with COVID-19 and Toxoplasma gondii: a cross-sectional study.COVID-19 突破性感染与弓形虫感染的相关性:一项横断面研究。
Sci Rep. 2023 Oct 17;13(1):17636. doi: 10.1038/s41598-023-44616-3.
6
Comparative Assessment of the Kinetics of Cellular and Humoral Immune Responses to COVID-19 Vaccination in Cancer Patients.比较癌症患者对 COVID-19 疫苗接种的细胞和体液免疫应答动力学。
Viruses. 2023 Jun 26;15(7):1439. doi: 10.3390/v15071439.
7
Prevalence of tuberculosis/COVID-19 co-infection and factors associated with SARS-CoV-2 infection in pulmonary tuberculosis patients at a respiratory diseases center: a cross-sectional study.呼吸道疾病中心肺结核患者中结核/COVID-19 双重感染的流行情况以及与 SARS-CoV-2 感染相关的因素:一项横断面研究。
Pan Afr Med J. 2023 Apr 28;44:204. doi: 10.11604/pamj.2023.44.204.38541. eCollection 2023.
8
Co-infection of COVID-19 and parasitic diseases: A systematic review.新型冠状病毒肺炎与寄生虫病的合并感染:一项系统综述。
Parasite Epidemiol Control. 2023 May;21:e00299. doi: 10.1016/j.parepi.2023.e00299. Epub 2023 Mar 30.
9
Neurological damages in COVID-19 patients: Mechanisms and preventive interventions.新冠病毒感染患者的神经损伤:机制与预防干预措施
MedComm (2020). 2023 Apr 6;4(2):e247. doi: 10.1002/mco2.247. eCollection 2023 Apr.
10
A latent pathogen infection classification system that would significantly increase healthcare safety.一个潜在病原体感染分类系统,将极大地提高医疗保健安全性。
Immunol Res. 2023 Oct;71(5):673-677. doi: 10.1007/s12026-023-09377-1. Epub 2023 Apr 3.
未能在初始阶段控制住全球 COVID-19 疫情中心。
J Med Virol. 2020 Jul;92(7):863-867. doi: 10.1002/jmv.25883. Epub 2020 Apr 28.
4
Clinical and immunological features of severe and moderate coronavirus disease 2019.新型冠状病毒病 2019 重症和中度患者的临床和免疫学特征。
J Clin Invest. 2020 May 1;130(5):2620-2629. doi: 10.1172/JCI137244.
5
Therapeutic options for the 2019 novel coronavirus (2019-nCoV).2019新型冠状病毒(2019-nCoV)的治疗选择。
Nat Rev Drug Discov. 2020 Mar;19(3):149-150. doi: 10.1038/d41573-020-00016-0.
6
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
7
Do Toxoplasma gondii apicoplast proteins have antigenic potential? An in silico study.刚地弓形虫顶质体蛋白是否具有抗原性?一项计算机研究。
Comput Biol Chem. 2020 Feb;84:107158. doi: 10.1016/j.compbiolchem.2019.107158. Epub 2019 Nov 6.
8
Infection against infection: parasite antagonism against parasites, viruses and bacteria.感染对抗感染:寄生虫对抗寄生虫、病毒和细菌的拮抗作用。
Infect Dis Poverty. 2019 Jun 15;8(1):49. doi: 10.1186/s40249-019-0560-6.
9
The Nucleotide Sensor ZBP1 and Kinase RIPK3 Induce the Enzyme IRG1 to Promote an Antiviral Metabolic State in Neurons.核苷酸传感器 ZBP1 和激酶 RIPK3 诱导酶 IRG1 在神经元中促进抗病毒代谢状态。
Immunity. 2019 Jan 15;50(1):64-76.e4. doi: 10.1016/j.immuni.2018.11.017. Epub 2019 Jan 8.
10
The Dual Nature of Type I and Type II Interferons.Ⅰ型和Ⅱ型干扰素的双重性质。
Front Immunol. 2018 Sep 11;9:2061. doi: 10.3389/fimmu.2018.02061. eCollection 2018.